Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

Study ID: NCT03258567
Start Date: 2018-04-26
End Date: 2031-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Nivolumab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

Study ID: NCT04472767
Start Date: 2020-08-07
End Date: 2027-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Nivolumab

Ipilimumab

Cabozantinib

Transarterial Chemoembolization

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC

Study ID: NCT02905591
Start Date: 2018-11-16
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

46

Intervention / Treatment

Radiation Therapy

Paclitaxel

Carboplatin

Ascorbic Acid

Sponsor

Joseph J. Cullen, MD, FACS

Source: clinicaltrials.gov

Share:
Add to list

Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.

Study ID: NCT04839991
Start Date: 2021-06-08
End Date: 2024-09-25
Study Type

Interventional

Study Phase

Phase1

No. of Participants

70

Intervention / Treatment

Seven 07

Sponsor

Crescendo Biologics Ltd.

Source: clinicaltrials.gov

Share:
Add to list

A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer

Study ID: NCT06396091
Start Date: 2024-07-22
End Date: 2026-07-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

zolbetuximab

mFOLFIRINOX

Sponsor

Astellas Pharma Global Development, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

Study ID: NCT05766891
Start Date: 2023-10-12
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

225

Intervention / Treatment

Group 1

Group 2

Group 3

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

Study ID: NCT05629494
Start Date: 2022-09-27
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

198

Intervention / Treatment

Ibuprofen 400 mg, TID

PSA test

Sponsor

Albany Medical College

Source: clinicaltrials.gov

Share:
Add to list

Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Study ID: NCT05613894
Start Date: 2023-07-14
End Date: 2028-05-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

33

Intervention / Treatment

Cabozantinib

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

Study ID: NCT05166694
Start Date: 2022-11-30
End Date: 2027-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1300

Intervention / Treatment

Drug-Drug Interaction Profile

Drug-Gene Interaction Profile

Standard of Care

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Caris Biorepository Research Protocol

Study ID: NCT01499394
Start Date: 2010-11
End Date: 2025-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100000

Intervention / Treatment
Sponsor

Caris Science, Inc.

Source: clinicaltrials.gov

Share:
Add to list